Pinnacle Financial Partners Inc Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pinnacle Financial Partners Inc increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,492 shares of the medical equipment provider’s stock after buying an additional 972 shares during the quarter. Pinnacle Financial Partners Inc’s holdings in Intuitive Surgical were worth $11,050,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Mirador Capital Partners LP increased its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after acquiring an additional 50 shares during the last quarter. Advisors Asset Management Inc. boosted its holdings in shares of Intuitive Surgical by 18.1% during the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after buying an additional 1,129 shares during the period. Consolidated Planning Corp lifted its stake in shares of Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after buying an additional 1,198 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of Intuitive Surgical by 617.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after buying an additional 76,649 shares in the last quarter. Finally, Brookstone Capital Management lifted its position in shares of Intuitive Surgical by 22.4% during the 2nd quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock worth $5,340,000 after buying an additional 2,289 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.2 %

Shares of ISRG opened at $537.07 on Wednesday. The stock has a market cap of $191.29 billion, a PE ratio of 86.35, a P/E/G ratio of 5.27 and a beta of 1.39. The business’s 50-day moving average price is $495.85 and its 200-day moving average price is $455.08. Intuitive Surgical, Inc. has a twelve month low of $281.12 and a twelve month high of $542.59.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 91,178 shares of company stock valued at $45,897,071. Insiders own 0.80% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price objective for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Mizuho raised their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Wells Fargo & Company upped their target price on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Finally, Stifel Nicolaus raised their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.